The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Evidence · Study critique · continued

A well-designed study with a badly written abstract posts 91–120

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.

EV
e.vargaTL218 May 2025#91

Understood. Thank you for being specific about the limits of it.

28 likes 14mo
BN
bench_notesTL419 May 2025#92
KP
k.perrinTL219 May 2025 · edited#93

Criticism is more useful when it is narrower. "The trial answers a different question from the one being asked" is actionable; "the trial is flawed" is not.

That matches what I was told, which is not the same as knowing it.

5 likes 14mo
AB
a.batistaTL220 May 2025#94

A request rather than an answer: could whoever has the primary source for well-designed study post it? I have seen the claim three times this month and each version had lost a qualifier.

0 likes 14mo
AN
a.nwosuTL220 May 2025#95
z.nakamura, post #25: Building on post #22 rather than restating it. Reporting bias within a paper — a result in a figure that is absent from the abstract — is checkable and is worth checking when the claim matters. Go to post

Worth separating two things that post #93 runs together.

Well-designed study has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.

0 likes in reply to #25 14mo
DT
d.tammTL221 May 2025#96
m.ramos, post #4: Answering the question post #2 raises rather than the one it answers. One caution on well-designed study: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated. Go to post

This follows post #93 rather than contradicting it.

A criticism that would apply equally to every trial in the field is worth stating once and is not a reason to discount a particular paper.

I am reporting what happened, not recommending it.

19 likes in reply to #4 14mo
AZ
a.zamoraTL221 May 2025#97

I would rather this thread reach "we do not know" about well-designed study than reach a confident answer that nobody can support when asked.

8 likes 14mo
OV
o.vogelTL222 May 2025#98

The most useful thing anyone has posted about well-designed study in this category was a table of what had been measured and by whom. That is what I would want again.

2 likes 14mo
HF
h.falkTL222 May 2025 · edited#99
k.perrin, post #93: Criticism is more useful when it is narrower. "The trial answers a different question from the one being asked" is actionable; "the trial is flawed" is not. That matches what I was told, which is not the same as knowing it. Go to post

Reporting bias within a paper — a result in a figure that is absent from the abstract — is checkable and is worth checking when the claim matters.

Flagging that the sources on this are thinner than the confidence in the thread suggests.

0 likes in reply to #93 14mo
EF
e.ferreiraTL3Regular23 May 2025#100

Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and secondary analyses are weaker evidence.

I am aware this is the third time this month I have made this point.

27 likes 14mo
SD
st.dialloTL223 May 2025#101
H
HHidalgoTL2Member23 May 2025#102
a.westergaard, post #39: The question underneath well-designed study is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you would expect to see under each hypothesis before you collect anything. If they predict the same observation, collecting it will not help. Go to post

Post #100 answers the question as asked. The question underneath it is different.

The bit of well-designed study that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread will converge.

24 likes in reply to #39 14mo
BC
b.correiaTL224 May 2025#103

Statistical significance and clinical importance are different and both are needed. A significant difference below the minimal important difference is a real finding of no practical consequence.

This is the sort of thing the wiki should carry and currently does not.

11 likes 14mo
BS
buffer_shiftTL1Member24 May 2025#104

Generalisability and validity are separate axes. A trial can be internally impeccable and still tell you nothing about the person asking.

Reading it again, the caveat matters more than the finding.

16 likes 14mo
EN
e.ndiayeTL225 May 2025#105
e.halonen, post #74: The pre-specified endpoint being a weaker proxy than you would like is a real criticism. It is a smaller one than saying the result was chosen after the fact. That is the honest state of it as of this week. Go to post

Surrogate endpoints are not automatically bad and their validity is compound-specific and population-specific. The question is whether this surrogate has been validated for this use.

Adding a source would improve this post and I do not have one to hand.

6 likes in reply to #74 14mo
DS
d.szymanskiTL3Wiki editor25 May 2025#106

Adding thanks rather than a view. I do not have a view worth the space.

1 like 14mo
EF
e.ferreiraTL3Regular26 May 2025#107

On post #105 — agreed on the reasoning, with one qualification.

The arithmetic on well-designed study is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.

0 likes 14mo
K
KAnderssonTL3Regular26 May 2025#108

My position on well-designed study is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.

23 likes 14mo
IG
i.guerreroTL227 May 2025#109

I had written a reply contradicting post #105 and deleted it. Here is what survived.

Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism but requires specificity about which real people and why the difference matters.

Scoping that to what I have actually seen rather than what I have read.

25 likes 14mo
TD
titration_diaryTL3Regular27 May 2025 · edited#110
to.varga, post #65: Where I have landed on well-designed study, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has borrowed it from somewhere that did not measure it. Go to post

Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is more idiosyncratic. That does not make it wrong but it is worth noticing.

Happy to expand any of that if it is the useful part.

12 likes in reply to #65 14mo
HD
h.delgadoTL227 May 2025#111

I would keep well-designed study and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is why the last one went badly.

7 likes 14mo
IT
impurity_tableTL3Analytical chemist28 May 2025 · edited#112

That matches what I have seen, for whatever a single anecdote is worth.

17 likes 14mo
NL
n.laurentTL228 May 2025#113

This follows post #111 rather than contradicting it.

Small methodological point on well-designed study: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.

0 likes 14mo
CR
compounding_ruthTL4Pharmacist29 May 2025#114
g.tanaka, post #46: Attrition is the failure mode most likely to invalidate a result and the least likely to be discussed. Differential attrition between arms is the specific thing to look for. Noting that I have skin in this question and have tried to discount for it. Go to post

Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism but requires specificity about which real people and why the difference matters.

0 likes in reply to #46 14mo
MS
m.steinerTL229 May 2025#115

Careful with the language on well-designed study. "Not detected" and "not present" are different findings and the first is a statement about the method.

11 likes 14mo
FD
f.demirTL2Regular30 May 2025#116

The practical version of well-designed study is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.

24 likes 14mo
SO
s.ostergaardTL230 May 2025#117

Picking up post #116: that is the part I would want checked first.

The pre-specified endpoint being a weaker proxy than you would like is a real criticism. It is a smaller one than saying the result was chosen after the fact.

Marking that as an opinion rather than a finding.

0 likes 14mo
BV
bias_varianceTL4Biostatistician30 May 2025#118
l.aaltonen, post #60: Appreciated. The plain phrasing does more work here than a longer post would. Go to post

On post #114 — agreed on the reasoning, with one qualification.

Well-designed study looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.

1 like in reply to #60 14mo
NP
n.petrovTL231 May 2025 · edited#119

Post #116 is the version of this I will quote in future. One addition.

The thing about well-designed study that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.

0 likes 14mo
BN
b.nilsenTL231 May 2025#120

Attrition is the failure mode most likely to invalidate a result and the least likely to be discussed. Differential attrition between arms is the specific thing to look for.

0 likes 14mo